Cyclic AMP and Butyrate Modulate Melatonin Synthesis in Y79 Human Retinoblastoma Cells

: Melatonin is synthesized by cultured Y79 human retinoblastoma cells and is secreted into the medium. Activity of the two key enzymes involved in the synthesis of melatonin, N‐acetyltransferase (NAT) and hydroxyindole‐O‐methyl‐transferase (HIOMT), are present in retinoblastoma cells. The activity o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurochemistry 1990-07, Vol.55 (1), p.208-214
Hauptverfasser: Wiechmann, Allan F., Kyritsis, Athanassios P., Fletcher, R. Theodore, Chader, Gerald J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 214
container_issue 1
container_start_page 208
container_title Journal of neurochemistry
container_volume 55
creator Wiechmann, Allan F.
Kyritsis, Athanassios P.
Fletcher, R. Theodore
Chader, Gerald J.
description : Melatonin is synthesized by cultured Y79 human retinoblastoma cells and is secreted into the medium. Activity of the two key enzymes involved in the synthesis of melatonin, N‐acetyltransferase (NAT) and hydroxyindole‐O‐methyl‐transferase (HIOMT), are present in retinoblastoma cells. The activity of these enzymes and the resulting synthesis and release of melatonin are modulated by the addition of a cyclic AMP analogue and butyrate to the culture medium. Melatonin levels increase dramatically over control levels after the addition of dibutyryl cyclic AMP (dbcAMP), whereas melatonin levels decrease after butyrate treatment. HIOMT activity is inhibited by both dbcAMP and butyrate, and NAT activity is stimulated by both of these differentiating agents, suggesting that the rise in melatonin levels in response to dbcAMP is the result of increased activity of NAT, whereas the decline in melatonin levels in response to butyrate may be due to a drop in HIOMT activity. Melatonin synthesis is dose‐ and time‐dependent, and the effect of dbcAMP is readily reversible, whereas the effect of butyrate does not appear to be reversible. These effects probably reflect basic differences in the regulatory mechanisms of the inducing agents.
doi_str_mv 10.1111/j.1471-4159.1990.tb08840.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79835104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79835104</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4308-4b71250e7a2a6a33e4b5958e5845a15d6a155249e5a50ac21bfdc419a27b1ee33</originalsourceid><addsrcrecordid>eNqVkF1r1UAQhhex1GP1JwiLoHeJO_uRZL0QatBWaVW0FbxaJps5mEM-2mxCm39v0hPqZele7OzyvjPz8jD2GkQM83m3i0GnEGkwNgZrRTwUIsu0iG-fsM299JRthJAyUkLLZ-x5CDshINEJHLJDCYlUqdmw3_nk68rz4_MfHNuSfxyHqceB-HlXjvXdg-bStVXLf03t8JdCFfj8-ZNafjo22PKfNFRtV9QYhq5BnlNdhxfsYIt1oJdrPWKXnz9d5KfR2feTL_nxWeS1ElmkixSkEZSixASVIl0YazIymTYIpkzmy0htyaAR6CUU29JrsCjTAoiUOmJv93Ov-u56pDC4pgp-ToAtdWNwqc2UAaEfNIJJNMhsmfh-b_R9F0JPW3fVVw32kwPhFvpu5xbEbkHsFvpupe9u5-ZX65axaKi8b11xz_qbVcfgsd722Poq_N9gZaKtXEJ82PtuqpqmRyRwX7_lUmTqHzW0oAs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15641283</pqid></control><display><type>article</type><title>Cyclic AMP and Butyrate Modulate Melatonin Synthesis in Y79 Human Retinoblastoma Cells</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wiechmann, Allan F. ; Kyritsis, Athanassios P. ; Fletcher, R. Theodore ; Chader, Gerald J.</creator><creatorcontrib>Wiechmann, Allan F. ; Kyritsis, Athanassios P. ; Fletcher, R. Theodore ; Chader, Gerald J.</creatorcontrib><description>: Melatonin is synthesized by cultured Y79 human retinoblastoma cells and is secreted into the medium. Activity of the two key enzymes involved in the synthesis of melatonin, N‐acetyltransferase (NAT) and hydroxyindole‐O‐methyl‐transferase (HIOMT), are present in retinoblastoma cells. The activity of these enzymes and the resulting synthesis and release of melatonin are modulated by the addition of a cyclic AMP analogue and butyrate to the culture medium. Melatonin levels increase dramatically over control levels after the addition of dibutyryl cyclic AMP (dbcAMP), whereas melatonin levels decrease after butyrate treatment. HIOMT activity is inhibited by both dbcAMP and butyrate, and NAT activity is stimulated by both of these differentiating agents, suggesting that the rise in melatonin levels in response to dbcAMP is the result of increased activity of NAT, whereas the decline in melatonin levels in response to butyrate may be due to a drop in HIOMT activity. Melatonin synthesis is dose‐ and time‐dependent, and the effect of dbcAMP is readily reversible, whereas the effect of butyrate does not appear to be reversible. These effects probably reflect basic differences in the regulatory mechanisms of the inducing agents.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1111/j.1471-4159.1990.tb08840.x</identifier><identifier>PMID: 2162375</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acetylserotonin O-Methyltransferase - metabolism ; Arylamine N-Acetyltransferase - metabolism ; Biological and medical sciences ; Bucladesine - pharmacology ; Butyrates - pharmacology ; Butyric Acid ; Eye Neoplasms - metabolism ; Eye Neoplasms - pathology ; Fundamental and applied biological sciences. Psychology ; Hormones and neuropeptides. Regulation ; Humans ; Hydroxyindole ; Hypothalamus. Hypophysis. Epiphysis. Urophysis ; Melatonin ; Melatonin - biosynthesis ; Neoplasm Proteins - metabolism ; N‐Acetyltransferase ; O‐methyltransferase ; Pineal ; Retina ; Retinoblastoma ; Retinoblastoma - metabolism ; Retinoblastoma - pathology ; Tumor Cells, Cultured ; Vertebrates: endocrinology</subject><ispartof>Journal of neurochemistry, 1990-07, Vol.55 (1), p.208-214</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4308-4b71250e7a2a6a33e4b5958e5845a15d6a155249e5a50ac21bfdc419a27b1ee33</citedby><cites>FETCH-LOGICAL-c4308-4b71250e7a2a6a33e4b5958e5845a15d6a155249e5a50ac21bfdc419a27b1ee33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1471-4159.1990.tb08840.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1471-4159.1990.tb08840.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19264923$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2162375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wiechmann, Allan F.</creatorcontrib><creatorcontrib>Kyritsis, Athanassios P.</creatorcontrib><creatorcontrib>Fletcher, R. Theodore</creatorcontrib><creatorcontrib>Chader, Gerald J.</creatorcontrib><title>Cyclic AMP and Butyrate Modulate Melatonin Synthesis in Y79 Human Retinoblastoma Cells</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>: Melatonin is synthesized by cultured Y79 human retinoblastoma cells and is secreted into the medium. Activity of the two key enzymes involved in the synthesis of melatonin, N‐acetyltransferase (NAT) and hydroxyindole‐O‐methyl‐transferase (HIOMT), are present in retinoblastoma cells. The activity of these enzymes and the resulting synthesis and release of melatonin are modulated by the addition of a cyclic AMP analogue and butyrate to the culture medium. Melatonin levels increase dramatically over control levels after the addition of dibutyryl cyclic AMP (dbcAMP), whereas melatonin levels decrease after butyrate treatment. HIOMT activity is inhibited by both dbcAMP and butyrate, and NAT activity is stimulated by both of these differentiating agents, suggesting that the rise in melatonin levels in response to dbcAMP is the result of increased activity of NAT, whereas the decline in melatonin levels in response to butyrate may be due to a drop in HIOMT activity. Melatonin synthesis is dose‐ and time‐dependent, and the effect of dbcAMP is readily reversible, whereas the effect of butyrate does not appear to be reversible. These effects probably reflect basic differences in the regulatory mechanisms of the inducing agents.</description><subject>Acetylserotonin O-Methyltransferase - metabolism</subject><subject>Arylamine N-Acetyltransferase - metabolism</subject><subject>Biological and medical sciences</subject><subject>Bucladesine - pharmacology</subject><subject>Butyrates - pharmacology</subject><subject>Butyric Acid</subject><subject>Eye Neoplasms - metabolism</subject><subject>Eye Neoplasms - pathology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hormones and neuropeptides. Regulation</subject><subject>Humans</subject><subject>Hydroxyindole</subject><subject>Hypothalamus. Hypophysis. Epiphysis. Urophysis</subject><subject>Melatonin</subject><subject>Melatonin - biosynthesis</subject><subject>Neoplasm Proteins - metabolism</subject><subject>N‐Acetyltransferase</subject><subject>O‐methyltransferase</subject><subject>Pineal</subject><subject>Retina</subject><subject>Retinoblastoma</subject><subject>Retinoblastoma - metabolism</subject><subject>Retinoblastoma - pathology</subject><subject>Tumor Cells, Cultured</subject><subject>Vertebrates: endocrinology</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkF1r1UAQhhex1GP1JwiLoHeJO_uRZL0QatBWaVW0FbxaJps5mEM-2mxCm39v0hPqZele7OzyvjPz8jD2GkQM83m3i0GnEGkwNgZrRTwUIsu0iG-fsM299JRthJAyUkLLZ-x5CDshINEJHLJDCYlUqdmw3_nk68rz4_MfHNuSfxyHqceB-HlXjvXdg-bStVXLf03t8JdCFfj8-ZNafjo22PKfNFRtV9QYhq5BnlNdhxfsYIt1oJdrPWKXnz9d5KfR2feTL_nxWeS1ElmkixSkEZSixASVIl0YazIymTYIpkzmy0htyaAR6CUU29JrsCjTAoiUOmJv93Ov-u56pDC4pgp-ToAtdWNwqc2UAaEfNIJJNMhsmfh-b_R9F0JPW3fVVw32kwPhFvpu5xbEbkHsFvpupe9u5-ZX65axaKi8b11xz_qbVcfgsd722Poq_N9gZaKtXEJ82PtuqpqmRyRwX7_lUmTqHzW0oAs</recordid><startdate>199007</startdate><enddate>199007</enddate><creator>Wiechmann, Allan F.</creator><creator>Kyritsis, Athanassios P.</creator><creator>Fletcher, R. Theodore</creator><creator>Chader, Gerald J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>199007</creationdate><title>Cyclic AMP and Butyrate Modulate Melatonin Synthesis in Y79 Human Retinoblastoma Cells</title><author>Wiechmann, Allan F. ; Kyritsis, Athanassios P. ; Fletcher, R. Theodore ; Chader, Gerald J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4308-4b71250e7a2a6a33e4b5958e5845a15d6a155249e5a50ac21bfdc419a27b1ee33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Acetylserotonin O-Methyltransferase - metabolism</topic><topic>Arylamine N-Acetyltransferase - metabolism</topic><topic>Biological and medical sciences</topic><topic>Bucladesine - pharmacology</topic><topic>Butyrates - pharmacology</topic><topic>Butyric Acid</topic><topic>Eye Neoplasms - metabolism</topic><topic>Eye Neoplasms - pathology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hormones and neuropeptides. Regulation</topic><topic>Humans</topic><topic>Hydroxyindole</topic><topic>Hypothalamus. Hypophysis. Epiphysis. Urophysis</topic><topic>Melatonin</topic><topic>Melatonin - biosynthesis</topic><topic>Neoplasm Proteins - metabolism</topic><topic>N‐Acetyltransferase</topic><topic>O‐methyltransferase</topic><topic>Pineal</topic><topic>Retina</topic><topic>Retinoblastoma</topic><topic>Retinoblastoma - metabolism</topic><topic>Retinoblastoma - pathology</topic><topic>Tumor Cells, Cultured</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiechmann, Allan F.</creatorcontrib><creatorcontrib>Kyritsis, Athanassios P.</creatorcontrib><creatorcontrib>Fletcher, R. Theodore</creatorcontrib><creatorcontrib>Chader, Gerald J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiechmann, Allan F.</au><au>Kyritsis, Athanassios P.</au><au>Fletcher, R. Theodore</au><au>Chader, Gerald J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclic AMP and Butyrate Modulate Melatonin Synthesis in Y79 Human Retinoblastoma Cells</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>1990-07</date><risdate>1990</risdate><volume>55</volume><issue>1</issue><spage>208</spage><epage>214</epage><pages>208-214</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>: Melatonin is synthesized by cultured Y79 human retinoblastoma cells and is secreted into the medium. Activity of the two key enzymes involved in the synthesis of melatonin, N‐acetyltransferase (NAT) and hydroxyindole‐O‐methyl‐transferase (HIOMT), are present in retinoblastoma cells. The activity of these enzymes and the resulting synthesis and release of melatonin are modulated by the addition of a cyclic AMP analogue and butyrate to the culture medium. Melatonin levels increase dramatically over control levels after the addition of dibutyryl cyclic AMP (dbcAMP), whereas melatonin levels decrease after butyrate treatment. HIOMT activity is inhibited by both dbcAMP and butyrate, and NAT activity is stimulated by both of these differentiating agents, suggesting that the rise in melatonin levels in response to dbcAMP is the result of increased activity of NAT, whereas the decline in melatonin levels in response to butyrate may be due to a drop in HIOMT activity. Melatonin synthesis is dose‐ and time‐dependent, and the effect of dbcAMP is readily reversible, whereas the effect of butyrate does not appear to be reversible. These effects probably reflect basic differences in the regulatory mechanisms of the inducing agents.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2162375</pmid><doi>10.1111/j.1471-4159.1990.tb08840.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 1990-07, Vol.55 (1), p.208-214
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_79835104
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Acetylserotonin O-Methyltransferase - metabolism
Arylamine N-Acetyltransferase - metabolism
Biological and medical sciences
Bucladesine - pharmacology
Butyrates - pharmacology
Butyric Acid
Eye Neoplasms - metabolism
Eye Neoplasms - pathology
Fundamental and applied biological sciences. Psychology
Hormones and neuropeptides. Regulation
Humans
Hydroxyindole
Hypothalamus. Hypophysis. Epiphysis. Urophysis
Melatonin
Melatonin - biosynthesis
Neoplasm Proteins - metabolism
N‐Acetyltransferase
O‐methyltransferase
Pineal
Retina
Retinoblastoma
Retinoblastoma - metabolism
Retinoblastoma - pathology
Tumor Cells, Cultured
Vertebrates: endocrinology
title Cyclic AMP and Butyrate Modulate Melatonin Synthesis in Y79 Human Retinoblastoma Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T00%3A06%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclic%20AMP%20and%20Butyrate%20Modulate%20Melatonin%20Synthesis%20in%20Y79%20Human%20Retinoblastoma%20Cells&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Wiechmann,%20Allan%20F.&rft.date=1990-07&rft.volume=55&rft.issue=1&rft.spage=208&rft.epage=214&rft.pages=208-214&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1111/j.1471-4159.1990.tb08840.x&rft_dat=%3Cproquest_cross%3E79835104%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15641283&rft_id=info:pmid/2162375&rfr_iscdi=true